Global Cervical Cancer Vaccine Market Size By Product Type (Gardasil, Gardasil 9, and Cervarix), By Distribution Channel (Hospitals, Government Entities, and Clinics), By Geography Scope And Forecast

Cervical Cancer Vaccine Market Size And Forecast

Cervical Cancer Vaccine Market size was valued at USD 506.11 Million in 2022, and the market size will reach USD 1437.67 Million by 2030, growing at a CAGR of 13.94% from 2023 to 2030.

The rising rate of cervical cancer among women is of particular concern because it may be a significantly common form of cancer and the number one reason for death. Its increasing prevalence worldwide is a major driver for the Cervical Cancer Vaccine Market. The worldwide surge in the number of cervical cancer patients, especially in developing countries, has motivated key players to develop new vaccines at a low cost. Furthermore, the growing incidence of cervical cancer has provoked governments and non-profit organizations to entail the initiative to make awareness regarding the control & prevention of cervical cancer and HPV vaccinations. The Global Cervical Cancer Vaccine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cervical Cancer Vaccine Market Definition

Cervical cancer is a type of cancer that occurs in the cervix of the female body, at the opening of the womb from the vagina. The early symptoms of cervical cancer include unusual vaginal bleeding, such as bleeding after sex or between periods. Almost all cases of cervical cancer are caused by a very common virus called human papillomavirus. Around 99% of all cervical cancer caused due to infection with high-risk human papillomaviruses (HPV). HPV develops an abnormal growth of the tissue at the cervix if the infection stays inside the cervix for a long time. Thus, certain abnormal growth of the tissues such as warts can lead to cancer in the cervix.

Treatments for cervical cancer include surgery, radiotherapy, and chemotherapy. According to World Health Organization, Cervical cancer is the fourth most common type of cancer in women around the world. But the preventive measures can reduce the risk of increasing positive cases around the world. Cervical cancer vaccination plays a vital role in the prevention of the HPV infection that causes cervical cancer in women. The HPV vaccine helps to protect the body against infection with human papillomavirus or HPV that results in causing cancers.

The vaccine can prevent most cases of cervical cancer if given before a girl or woman is exposed to the virus. The World Health Organization has recommended HPV vaccine for girls of ages 11 or 12 through national immunization programs. Although the vaccine can be given as early as age 9 before they have sexual contact and are exposed to HPV. According to the Centers for Disease Control and Prevention (CDC), it is recommended to receive two doses of HPV vaccine at intervals of six months. Nowadays, it not necessary to take a three-dose schedule as previously directed.

Global Cervical Cancer Vaccine Market Overview

Cervical cancer cases are increasing globally, which may increase the demand for cervical vaccines. According to the American Cancer Society, 14,480 new cases of invasive cervical cancer will be diagnosed in the United States in 2021. Furthermore, around 4,290 women will die from cervical cancer, which was historically one of the leading causes of cancer death in American women. The Cervical Cancer Vaccine ensures the persistence of particular antibodies against HPV infection for the rest of one’s life. The effectiveness and acceptability of the Cervical Cancer Vaccine would be considerably enhanced if the protection was long-lasting and did not require regular boosters throughout life. As a result, the efficiency of the vaccine is critical.

Although investigations and research have found no deaths associated with any HPV vaccine, there are some side effects. These are minor, but they have the potential to become a major market constraint. According to the American Cancer Society, the HPV vaccine might cause headaches, fevers, nausea, and dizziness. Furthermore, the establishment of a national immunization program in developing and underdeveloped nations can expand the global Cervical Cancer Vaccine Market.

Global Cervical Cancer Vaccine MarketSegmentation Analysis

The Global Cervical Cancer Vaccine Market is segmented Based on Product Type, Distribution Channel, And Geography.

Cervical Cancer Vaccine Market, By Product Type

• Gardasil
• Gardasil 9
• Cervarix

Based on Product Type, the market is bifurcated into Gardasil, Gardasil 9, and Cervarix. Gardasil accounted for the largest market share in 2020 and is projected to grow at a CAGR of 14.42% during the forecast period. Gardasil is a human papillomavirus (HPV) vaccine. It is a suspension for injection that contains purified proteins for four types of human papillomavirus (types 6, 11, 16, and 18). It is available in vials or prefilled syringes. Gardasil is used in males and females from the age of nine years to protect against the following conditions caused by specific types of human papillomavirus (HPV) such as precancerous lesions (growths) in the cervix, vulva or vagina and anus; cervical and anal cancers; genital warts.

Cervical Cancer Vaccine Market, By Distribution Channel

• Hospitals
• Government Entities
• Clinics

Based on Distribution Channel, the market has been segmented into Hospitals, Government Entities, and Clinics. Hospitals accounted for the largest market share in 2020 and are projected to grow at the highest CAGR of 14.65% during the forecast period. Government Entities was the second-largest market in 2020, and it is projected to grow at the highest CAGR.

Cervical Cancer Vaccine Market, By Geography

• Asia Pacific
• Middle East & Africa
• Latin America

On the basis of Geography, the market is classified into Asia Pacific, Middle East & Africa, and Latin America. The Asia Pacific accounted for the largest market share and the Middle East & Africa was the second-largest market in 2020. Asia’s economy continues to grow steadily, with strong progress in trading. The region is one of the leading and fastest-growing economies in the global market. The Asia Pacific region is likely to witness the highest growth in the global cervical cancer vaccine market over the forecast period owing to the extension of the already strong biologics market in the region, and the availability of screening tests and vaccine development potential as well.

Key Players

The “Global Cervical Cancer Vaccine Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck & Co. Inc., GlaxoSmithKline plc., Sanofi, AstraZeneca PLC, Bristol, and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In February 2021, Merck acquired Pandion, a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases.
• In June 2021, Sanofi partnered with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor-positive breast cancer.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Cervical Cancer Vaccine Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The Porter’s five forces model can be used to assess the competitive landscape in Cervical Cancer Vaccine Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

<a href="https//www.marketresearch.com/wp-content/uploads/2021/06/Porters-Five